Mikhail Blagosklonny: A Beacon of Hope for Many People Globally

Rapamycin extends life and subsequently health span because it slows down aging. Many have wondered how this is possible since, in essence, aging is believed to be the increase of the probability of death. Aging can scientifically be defined as the exponential increase of the probability of death with age. Age related illnesses such as diabetes, cancer and hypertension are biomarkers of aging. Aging processes do not emanate from nothing. The cause of aging is the changes in organs, tissues, cellular and even the functioning of sytems within the body.

Rapamycin is believed to extend the lifespan independent of its anti-cancer effect and curbs cancer by slowing down the process of aging. It is worth noting that cancer is an aging related disease. Therefore, measures that slow down aging are also likely to aid in the delay of cancer. Rapamycin inhibits the MTOR (mechanistic or mammalian target of rapamycin). Hence, it is highly anticipated that if Rapamycin slows aging, it should without a shadow of doubt delay cancer. MTOR is adversely involved in aged related illnesses, and rapamycin curbs them in mammals and subsequently slows down the process of aging. Rapamycin suppresses geroconversion, which is the basis of organismal aging. Rapamycin is also vital in the extension of lifespan in all species and learn more about Mikhail.

Mikhail Blagosklonny is a seasoned professor, researcher, philanthropist and an individual who strives to make the world a better place for those seeking treatment despite their economic strengths. Mikhail Blagosklonny’s main interest is in the vast field of medical research. He specializes in cancer and aging. He is a professor at Roswell Park Institute, where he teaches Oncology. The connection between aging and cancer, and the reason why cancer is prevalent among aged people is what draws his attention the most.

Mikhail Blagosklonny is a prominent person and many of his peers and students look up to him for advice and mentorship. Many students, who aspire to continue with his research in future, also take advantage of his availability, vast knowledge and experience that he has accumulated over the years. He is very optimistic that he will inspire and nurture many willing people in the whole world to leave off his extensive research. He refers to cancer as a dangerous and tragic disease, and that is why he is so determined towards finding the magic healing and more information click here.

Mikhail’s main vision is to discover a way of treating cancer that is less painful to the patient, affordable and effective. He also hopes to find a way that the cancerous cells can be eradicated from the body without altering the normal functioning of the normal cells, specifically very vital cells for the recovery of mind and the body after difficult months or even years of cancer treatment. He has made tremendous efforts and hopes that one day his dream of coming up with cancer treatment will come to pass. Mikhail strongly believes that when the cancer cure is discovered, it is not only going to be for the rich but for everyone in the society regardless of their economic status and resume his.

Oncotarget – Technological Research At Its Best

There is a great need to spread scientific information and news to the public via a fast and accurate platform and Oncotarget has proven that they could be this platform. Their goal is to help researchers spread their information in both a fast and well-organized manner by utilizing a system of well-organized peer-reviews. While there have been other sites in the past that have attempted to provide the service Oncotarget provides, none match its quality and speed that is needed in the field of Scientific and Technological research.

Oncotarget is a journal that provides free access to users around the world. Oncotarget provides weekly issues of papers online that can be read by anyone to educate themselves about scientific results. Papers can be printed, or they can be used online. The mission of Oncotarget is to make scientific results widely available to the public which enables Oncotarget to maximize its research capabilities. Under the leadership of scientists that are well known, Oncotarget has been able to help researchers contribute to solving cures for diseases. Having life without disease is the main goal that Oncotarget wants to accomplish. Due to the huge success of Oncotarget and its publishers, it has launched sections that go beyond oncology. Oncotarget is also available on Dove Press.

Of the people working at Oncotarget, the Co-Editor-in-Chief Mikhail Blagosklonny is someone that has worked to improve the world by applying his knowledge of topics like Biogerontology in order to create the best method of maximizing research. His pursuit of creating life without disease via an enhanced ability to share information among fellow colleagues is not only noble but is also a needed improvement for our current society.

Without a doubt, Oncotarget and their staff of bright individuals has and will continue to display the way that research is done. Follow Oncotarget on Twitter.